Book a visit
  1. Home
  2. Knowledge
  3. Witaminy i minerały

Vitamin K2

Witaminy i minerały Published: 15.09.2015

Traditionally, vitamin K was regarded as a factor required for blood clotting, but recent research shows that vitamin K2 is involved in a range of other important bodily functions. One very important function appears to be activating and strengthening Gla proteins (17 have been discovered so far).

How does vitamin K2 affect health?

Bone mineral density (BMD).

The effect on bone density was observed in patients with hip fractures, who had very low vitamin K2 levels. A strong link between vitamin K2 deficiency and bone health disorders has been shown by both clinical and laboratory studies. Vitamin K2 deficiency was found to reduce osteocalcin levels, which in turn increases bone fragility. Studies have also shown that only vitamin K2 (K1 does not have this effect), combined with calcium and vitamin D, can increase bone strength by improving bone geometry. In addition, research by M.H.J. Knapen, L.J. Schurgers and C. Vermeer clearly showed that vitamin K2 is essential for maintaining adequate bone strength in post-menopausal women and helps improve bone mineral content and femoral neck width.

More arguments supporting the unique functions of vitamin K2 come from Japan. The Japanese population appears to have a lower risk of fractures than Europeans and Americans. This would be paradoxical if calcium intake were the only factor determining bone density. However, studies carried out in Japan and published in 2006 and 2008 link the higher BMD of the Japanese to the widespread consumption of natto, a traditional breakfast dish made from fermented soya beans. A higher intake of vitamin K2 MK-7, present in natto, appears to increase osteocalcin activation and significantly reduce the risk of fractures.

Calcification of the heart

Patients with osteoporosis have extensive calcium plaques in their arteries that reduce blood flow. Too much calcium in one part of the body (the arteries) and too little in another (the bones) – which can occur even despite calcium supplementation – is called the calcium paradox. The main reason is vitamin K2 deficiency, which leads to a significant loss of the biological function of MGP proteins, which are the best at preventing calcification of the blood vessels. Fortunately, animal studies have shown that vascular calcification can not only be prevented, but blood vessels can also be restored to normal by increasing daily vitamin K2 intake.

Children's health.

Children's bones grow much faster than adults', so they need vitamin K2 in much larger amounts. The results of many studies, however, point to a clear vitamin K2 deficiency in the bones. Most of the children studied had significantly raised levels of decarboxylated osteocalcin, which indicates low vitamin K2 levels.

How are K vitamins absorbed?

Vitamin K is taken up from the small intestine and transported by chylomicrons into the bloodstream. Most vitamin K1 is carried by triacylglycerol-rich lipoproteins (TRL) and unfortunately quickly removed by the liver. Only a small amount is released into the bloodstream, where it is carried by cholesterol (LDL and HDL). Vitamin K2 MK-4 is transported by the same lipoproteins (TRL, LDL and HDL) and is removed from the body just as quickly. Vitamin K2 MK-7 (long-chain menaquinones) is absorbed in the same way as vitamin K1 and K2 MK-4, but it is more efficiently redistributed by the liver and incorporated mainly into low-density lipoproteins (LDL). Vitamin K2 MK-7 in LDL has a long half-life in the bloodstream and can circulate for longer, which results in higher bioavailability for tissues outside the liver compared with vitamin K1 and K2 MK-4. The accumulation of vitamin K in tissues outside the liver is directly relevant to the functions of vitamin K not related to blood clotting and fibrinolysis.

Where to find K vitamins and how much does the body need?

In 2012 the Canadian author and natural medicine expert Kate Rhéaume-Bleue proposed increasing the recommended dietary allowance (RDA) for vitamin K (currently 80–120 µg), as this standard may be too low.

The highest concentrations of vitamin K1 are found in green leafy vegetables; significant amounts are also present in some vegetable oils, fruit, grains and dairy products. In Europe and the United States, 60% or more of vitamin K1 comes from eating green leafy vegetables. Dietary vitamin K1 intake is similar in many countries, at around 70–80 µg, which is below the recommended intake of vitamin K. Apart from animal livers, the richest dietary source of vitamin K2 (long-chain menaquinones) is fermented food (fermented by bacteria only), usually represented by cheeses (MK-8, MK-9) in Western diets and natto (MK-7) in Japan.

Natural K2 is also found in bacterially fermented foods such as mature cheeses and curd cheese. K2 MK-4 is found in relatively small amounts in meat and eggs.

There are two kinds of vitamin K2 deficiency: acute and chronic.

Acute deficiency is generally recognised as being characterised by bleeding from the gums, nose and digestive tract. The consequences can be very serious: stroke, lung damage and death from heavy blood loss. Newborns are at greater risk of acute vitamin K2 deficiency, because vitamin K2 does not cross the placenta sufficiently and the newborn has not yet developed the gut flora that can produce it. Vitamin K2 deficiency can also occur due to the use of anticoagulants (e.g. warfarin or other coumarin derivatives), long-term antibiotic use, gallbladder disease and Crohn's disease.

Chronic vitamin K2 deficiency is less obvious to diagnose than acute deficiency. This makes it more dangerous, because there are no alarming symptoms or test results, and weakened bones and a weakened circulatory system are regarded as diseases of ageing.

For a long time vitamin K2 deficiency was thought to be rare, and the required level could easily be supplied by diet and microbial biosynthesis by bacteria living in the gut. However, recent scientific data indicate that the amount of vitamin K2 in the diet is not as high as once thought. Even a well-balanced diet may not supply enough vitamin K to meet the body's needs. A 2005 study by C.J. Prynne showed that vitamin K2 intake is now much lower than 50 years earlier, and daily vitamin K intake has been gradually decreasing since 1950.

This can be partly explained by changes in eating habits (people eat far fewer green leafy vegetables, which are rich in vitamin K1) and changes in food production. Today's sterile food production conditions, dictated by international standards, mean that the various bacterial species that produce vitamin K2 are absent from the diet.

Sources of vitamin K2 have also changed over the decades. For example, in 1950 about 15% of vitamin K2 in children's diets came from fats and oils and 55% from vegetables (excluding potatoes). In 1990, 35% came from fats and oils and only 30% from vegetables.

It has been shown that all K vitamins are absorbed from the digestive tract in the small intestine. The bacterial colonies that produce vitamin K2 are located in the colon (large intestine), where the bile salts needed to absorb vitamin K2 are absent. It follows that the effectiveness of intestinal absorption of vitamin K2 is questionable, and in addition the current recommended daily intake of vitamin K2 may be too low. The requirement for activating clotting factors is met, but there is too little vitamin K2 to activate all the functions it performs in the body.

Causes of vitamin K deficiency include:

  • a monotonous diet
  • eating artificial trans fats
  • the use of pesticides and artificial fertilisers in food production
  • eating junk food ("fast food") and large amounts of frozen food
  • eating products from poultry, pigs and cattle reared indoors and fed on compound feed (only grass-eating animals convert vitamin K1 into K2 MK-4, which has resulted in its absence from basic foods such as butter, eggs, cheese and meat)
  • an increased intake of artificial food and empty calories at the expense of natural fresh food
  • overuse of antibiotics by people, and of antibiotics and steroids in animal farming (this creates more and more antibiotic-resistant bacteria, which destroy the good gut flora)
  • the use of anticoagulants (e.g. warfarin and coumarin derivatives), gallbladder disease and Crohn's disease

How do anticoagulants (warfarin) affect vitamin K?

Recent studies have shown a clear link between long-term anticoagulant therapy and reduced bone strength due to a decrease in active osteocalcin. Long-term anticoagulant therapy can lead to more fractures, lower bone mineral content and density, osteopenia and raised serum levels of decarboxylated osteocalcin. Bone mineral density was significantly lower in stroke patients on long-term warfarin therapy than in patients not treated with warfarin. The osteopenia was the result of warfarin's effect on vitamin K2 metabolism. In addition, long-term anticoagulant therapy is often associated with soft tissue calcification in children and adults. Moreover, in people on long-term anticoagulant therapy, arterial calcification progressed twice as fast as in patients not taking a vitamin K antagonist. The consequences of long-term anticoagulant therapy include increased stiffness of the aortic walls, coronary insufficiency, ischaemia and even heart failure. Arterial calcification may also contribute to systolic hypertension and ventricular hypertrophy. By affecting vitamin K2 metabolism, coumarins can lead to excessive calcification of the cartilage and the arteries of the trachea.

Anticoagulant therapy is usually given to prevent conditions that threaten life and health. A high intake of vitamin K interferes with the action of anticoagulants. Patients treated with warfarin or another vitamin K antagonist are therefore advised not to eat foods rich in vitamin K. Recent studies suggest that combining vitamin K with anticoagulants to stabilise the INR (international normalised ratio – a standardised measure of plasma clotting time) may be the best solution – but this must be decided by the treating doctor.

Contraindications to vitamin K2 supplementation and safe dosage?

No toxic effects are known after taking large doses of menaquinones (vitamin K2 MK-7). People taking anticoagulants such as warfarin (coumarins) should consult their doctor before using vitamin K2. Unlike other fat-soluble vitamins, vitamin K2 is not stored in significant amounts in the liver. All research results available to date indicate that K vitamins have no negative effects on healthy people. Recommendations on daily vitamin K intake recently issued by the National Institutes of Health in the United States also confirm the wide safety margin of high doses of vitamin K: "No evidence of toxicity has been shown for vitamins K1 or K2. Only people taking anticoagulants such as warfarin (coumarins) should consult their doctor, as K vitamins may interfere with the action of these medicines."

Source: http://www.naturalna-medycyna.com.pl/

This article is for information and education only and does not replace medical advice. Please consult a doctor about any health problem. Legal notice.

Back to articles

Call Book a visit